These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 953613)

  • 1. Letter: Antipyrine half life and clearance in clinical practice.
    Whitling B; Ullah M; Meredith PA
    Br Med J; 1976 Aug; 2(6033):471. PubMed ID: 953613
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of stimulation of antipyrine and phenytoin metabolism by lithium carbonate in man.
    Perrild H; Hansen JM; Skovsted L; Simonsen K; Hegedüs L; Christensen LK
    Acta Pharmacol Toxicol (Copenh); 1983 Apr; 52(4):315-7. PubMed ID: 6408891
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between metronidazole and drugs eliminated by oxidative metabolism.
    Jensen JC; Gugler R
    Clin Pharmacol Ther; 1985 Apr; 37(4):407-10. PubMed ID: 3979002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.
    Neuvonen PJ; Tokola RA; Kaste M
    Eur J Clin Pharmacol; 1981; 21(3):215-20. PubMed ID: 7318881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between phenytoin and dichloralphenazone [proceedings].
    Riddell JG; Salem SA; McDevitt DG
    Br J Clin Pharmacol; 1980 Jan; 9(1):118P. PubMed ID: 7356880
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketoconazole does not impair antipyrine clearance in humans.
    Blyden GT; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):225-6. PubMed ID: 3733272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drug pretreatment on antipyrine elimination in the rabbit.
    Chambers DM; Jefferson GC
    Pharmacology; 1982; 24(2):88-95. PubMed ID: 7079291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug metabolism in malnourished children: a study with antipyrine.
    Homeida M; Karrar ZA; Roberts CJ
    Arch Dis Child; 1979 Apr; 54(4):299-302. PubMed ID: 110271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.
    Boxenbaum H
    J Pharmacokinet Biopharm; 1980 Apr; 8(2):165-76. PubMed ID: 6107379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monthly variations in the clearance of antipyrine in the rat.
    Bélanger PM; Doré F; Labrecque G
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
    Byrne E; Harman AW; Frewin DB; Hallpike JF
    Clin Exp Neurol; 1979; 16():183-9. PubMed ID: 550940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine.
    Sultatos LG; Dvorchik BH; Vesell ES; Shand DG; Branch RA
    Clin Pharmacokinet; 1980; 5(3):263-73. PubMed ID: 7389235
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy.
    Chiba K; Ishizaki T; Tabuchi T; Wagatsuma T; Nakazawa Y
    Obstet Gynecol; 1982 Nov; 60(5):620-6. PubMed ID: 6815599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Abernethy DR; Knüchel M
    Pharmacology; 1984; 28(4):188-95. PubMed ID: 6728897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of ranitidine on antipyrine metabolism (author's transl)].
    Staiger C; Simon B; de Vries J; Kather H; Walter E
    Z Gastroenterol; 1980 Dec; 18(12):601-4. PubMed ID: 6116365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.